Renal amyloidosis natural history, complications and prognosis
Xyz Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Renal amyloidosis natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Renal amyloidosis natural history, complications and prognosis |
FDA on Renal amyloidosis natural history, complications and prognosis |
CDC on Renal amyloidosis natural history, complications and prognosis |
Renal amyloidosis natural history, complications and prognosis in the news |
Blogs on Renal amyloidosis natural history, complications and prognosis |
Risk calculators and risk factors for Renal amyloidosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Natural History, Complications, and Prognosis
Natural History
- The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
- The symptoms of (disease name) typically develop ___ years after exposure to ___.
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
- Common complications of renal amyloidosis include:[1]
- Proteinuria (32%)
- Nephrotic syndrome (40%)
- Chronic renal failure (28%)
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
- Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
References
- ↑ Bilginer Y, Akpolat T, Ozen S (August 2011). "Renal amyloidosis in children". Pediatr. Nephrol. 26 (8): 1215–27. doi:10.1007/s00467-011-1797-x. PMC 3119800. PMID 21360109.